1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:MR imaging grades 2–3 ligament high signal intensity in patients with WAD1-2 12 months after injury and in noninjured controls with chronic neck pain
Group Alar Ligament Grades 2–3 High Signala Transverse Ligament Grades 2–3 High Signala n % Pb n % Pb WAD, NDI > 8% at follow-up (n = 45) 18 40.0 .681 12 26.7 .814 WAD, NDI ≤ 8% at follow-up (n = 46) 12 26.1 .058 10 21.7 1.000 All WAD (n = 91) 30 33.0 .151 22 24.2 1.000 Controls, all NDI > 8% (n = 52) 24 46.2 12 23.1